Dixon Technologies (India) Ltd209.99bn4.33bn843.70bn3.92k Panasonic Holdings Corp4.96tn181.16bn1.82tn228.42k Data as of Sep 27 2024. Currency figures normalised to Dixon Technologies (India) Ltd's reporting currency: Indian Rupee INR 17.63%Per cent of shares held by top holders ...
Dixon Technologies (india) Limited, lighting, decorative lighting and accessories,decorative lighting for special types of lamp ,decorative lighting style orientation: classic ,ceiling lights,standard lamps,wall lights,decorative lighting style orientati
Find More Stocks Use our equities screener to discover other potential opportunities. Go to the Equities Screener Your alerts 1D 3D 1W 1M 6M 1Y 3Y 5Y Compar Key statistics On Wednesday,Dixon Technologies (India) Ltd (DIXON:NSI)closed at 12,724.30, -6.71% below its 52-week high of 13,639...
Dixon Technologies下一财年的预估资本支出的一致预期均值是5.128十亿。. 查看Dixon Technologies (India) Ltd的资本支出的一致预期均值趋势、图表等
Shares of Oil India slipped 0.81 per cent to close at Rs 725.50 apiece, the scrip of Dixon Technologies India fell 2.05 per cent to settle at Rs 12,930.95 per piece, while Rail Vikas Nigam Ltd climbed 4.10 per cent to end at Rs 603.55 per piece on the NSE. Also, the scrip of ...
Dixon Technologies下一财年的预估预期无杠杆自由现金流是4.848十亿。 接下来 5 个财年,Dixon Technologies的预估预期无杠杆自由现金流均值是 11.343十亿。 接下来5个财年,Dixon Technologies的预期无杠杆自由现金流中值是11.725十亿。 指标使用情况:预期无杠杆自由现金流 (InvestingPro) ...
Dixon Technologies的股东应占净利润率复合年均增长率(7年)是1.0%. 查看Dixon Technologies (India) Ltd的股东应占净利润率复合年均增长率(7年)趋势、图表等
Dixon Technologies (India) Ltd的平均价格/最近12个月的自由现金流(FCF)(5年)为-56,046.2x,显著超出四分位距,因此被排除在分布之外。下表提供了更多数据的摘要: 板块非必需消费品的平均价格/最近12个月的自由现金流(FCF)(5年) 经济风险区类别 发展中 全部成分股 2,597 包括的成分股 2,493 分钟 -349.1x ...
我们发现下列公司与Dixon Technologies (India) Ltd相近,它们都属于相关的行业。我们还考虑了规模、增长和各种财务指标,并将列表缩小到以下范围。 Dixon Tech的下修每股收益的分析师比率,最近90天基准 名称代码下修每股收益的分析师比率,最近90天 Dixon Technologies (India) Ltd NSEI:DIXON - Amber Enterprises India...
Netweb Technologies India Limited wins award from Intel Corporation Jubilant Pharmova announces completion of USFDA audit of facility Located at Spokane, Washington, USA Biocon Ltd partners with Tabuk Pharmaceuticals to commercialize its Glucagon-like peptide-1 products in the Middle East region ...